“…For each experiment, cells from 3 -5 donors were pooled right after the isolation and then split into four samples ( ~ 2 ϫ 10 6 cells/ml), suspended in RPMI (Roswell Park Memorial Institute, Sigma-Aldrich, St Louis, MO, USA) 1640 medium, supplemented with 10% fetal calf serum (Sigma-Aldrich), and subjected to four diff erent treatments at room temperature (Ivanova et al 2010, Stankova et al 2011): (i) 4 h of incubation with RPMI before lysis; (ii) 2 h of incubation in RPMI, followed by in vitro irradiation with diff erent doses ranging from 0.5 -4 Gy (dose rate 2.07 Gy/min, 137 Cs gamma source, Gitawa Ltd, Sofi a, Bulgaria), incubation for another 2 h, and lysis; (iii) 4 h of incubation with 0.1 μ M MG132, 0.01 or 0.1 μ M lactacystin and 0.1 or 1 μ M celastrol in RPMI before lysis; and (iv) 2 h of incubation with the corresponding inhibitor, followed by irradiation with diff erent doses (from 0.5 -4 Gy), incubation for another 2 h and lysis. Th e three compounds, MG132, lactacystin and celastrol, were products of EMD Millipore, Darmstadt, Germany.…”